Latest News

No Relief from High Drug Costs in Sight
Prescription drug list prices outpaced the rate of inflation every year from 2006 to 2015.
Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, highlights emerging trends in the specialty pharmacy landscape.
Tisagenlecleucel (Kymriah) produced an overall response rate of 53% in patients with lymphoma.
Long-acting pre-exposure prophylaxis may improve adherence to HIV treatment.
Liver cancer is the most common cancer caused by diabetes and obesity.
Top news of the day from across the health care landscape.
Treating aging patients with immunomodulatory drugs further increases the risk of infections.
A proposed Sandoz biosimilar of pegfilgrastim (Neulasta) demonstrated biosimilarity to the reference biologic.


Specialty Drugs: Year in Review 2017 Part I
Specialty pharmaceuticals featured prominently in the actions of the FDA in 2017.
To date, significant uncertainty surrounds the adoption of digital health tools into clinical development programs and trial protocols.
Partnerships are key between home infusion and hospitals to alleviate costs on the health system.
Through value-based care initiatives, payers are increasingly holding both providers and pharmaceutical manufacturers accountable for choosing the right combination of drug regimens and treatment protocols.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


Ron Lanton III, Esq, president, True North Political Solutions, LLC, discusses how proposed legislations would affect pharmacy benefit manager relations with specialty pharmacies.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the importance of specialty pharmacists becoming certified and how it improves the industry as a whole.

Joel Wright, chief executive officer, AllianceRx Walgreens Prime discusses how specialty pharmacies can leverage retail pharmacies connections to negotiate costs.

Current Issue

Volume: 8
Number: 7

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.